{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T12:39:09Z","timestamp":1791722349417,"version":"4.3.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep04267","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T10:02:43Z","timestamp":1393927363000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies"],"prefix":"10.1038","volume":"4","author":[{"given":"Yaron","family":"Bram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Frydman-Marom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Gilead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Shaltiel-Karyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadav","family":"Amdursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Gazit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,4]]},"reference":[{"key":"BFsrep04267_CR1","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","volume":"148","author":"D Eisenberg","year":"2012","unstructured":"Eisenberg, D. & Jucker, M. The amyloid state of proteins in human diseases. Cell 148, 1188\u20131203 (2012).","journal-title":"Cell"},{"key":"BFsrep04267_CR2","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/BF02189111","volume":"246","author":"C Haass","year":"1996","unstructured":"Haass, C. The molecular significance of amyloid beta-peptide for Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 246, 118\u2013123 (1996).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"BFsrep04267_CR3","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","volume":"4","author":"KA Conway","year":"1998","unstructured":"Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318\u20131320 (1998).","journal-title":"Nat. Med."},{"key":"BFsrep04267_CR4","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s001250051060","volume":"41","author":"LM Chuang","year":"1998","unstructured":"Chuang, L. M. et al. Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity and type 2 diabetes mellitus in Taiwanese patients. Diabetologia. 41, 1250\u20131251 (1998).","journal-title":"Diabetologia."},{"key":"BFsrep04267_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology. 30, 572\u2013580 (1991).","journal-title":"Annals of Neurology."},{"key":"BFsrep04267_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","volume":"13","author":"DW Dickson","year":"1992","unstructured":"Dickson, D. W. et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13, 179\u2013189 (1992).","journal-title":"Neurobiol. Aging."},{"key":"BFsrep04267_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/geront\/37.2.150","volume":"37","author":"DA Snowdon","year":"1997","unstructured":"Snowdon, D. A. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 37, 150\u2013156 (1997).","journal-title":"Gerontologist"},{"key":"BFsrep04267_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/416507a","volume":"416","author":"M Bucciantini","year":"2002","unstructured":"Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507\u2013511 (2002).","journal-title":"Nature"},{"key":"BFsrep04267_CR9","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from A\u03b21-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U. S. A. 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04267_CR10","doi-asserted-by":"publisher","first-page":"32046","DOI":"10.1074\/jbc.M201750200","volume":"277","author":"KN Dahlgren","year":"2002","unstructured":"Dahlgren, K. N. et al. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046\u201332053 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04267_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535\u2013539 (2002).","journal-title":"Nature"},{"key":"BFsrep04267_CR12","doi-asserted-by":"publisher","first-page":"10427","DOI":"10.1073\/pnas.0502066102","volume":"102","author":"A Quist","year":"2005","unstructured":"Quist, A. et al. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U. S. A. 102, 10427\u201310432 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"BFsrep04267_CR13","doi-asserted-by":"publisher","first-page":"31374","DOI":"10.1074\/jbc.M400348200","volume":"279","author":"M Bucciantini","year":"2004","unstructured":"Bucciantini, M. et al. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J. Biol. Chem. 279, 31374\u201331382 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04267_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.bpj.2012.06.045","volume":"103","author":"MF Sciacca","year":"2012","unstructured":"Sciacca, M. F. et al. Two-step mechanism of membrane disruption by A\u03b2 through membrane fragmentation and pore formation. Biophys. J. 103, 702\u2013710 (2012).","journal-title":"Biophys. J."},{"key":"BFsrep04267_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486\u2013489 (2003).","journal-title":"Science"},{"key":"BFsrep04267_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.5.4.397","volume":"5","author":"EL Opie","year":"1901","unstructured":"Opie, E. L. On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes melutus. J. Exp. Med. 5, 397\u2013428 (1901).","journal-title":"J. Exp. Med."},{"key":"BFsrep04267_CR17","first-page":"968","volume":"14","author":"WA SE","year":"1901","unstructured":"SE, W. A. Zur Kenntnis der feineren Ver\u00e4nderungen des Pankreas bei Diabetes mellitus. Wien. Klin. Wochenshr. 14, 968\u2013972 (1901).","journal-title":"Wien. Klin. Wochenshr."},{"key":"BFsrep04267_CR18","first-page":"801","volume":"35","author":"ET Bell","year":"1959","unstructured":"Bell, E. T. Hyalinization of the islets of Langerhans in nondiabetic individuals. Am. J. Pathol. 35, 801\u2013805 (1959).","journal-title":"Am. J. Pathol."},{"key":"BFsrep04267_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/BF00544103","volume":"354","author":"P Westermark","year":"1971","unstructured":"Westermark, P. Mast cells in the islets of Langerhans in insular amyloidosis. Virchows Arch. A Pathol. Pathol. Anat. 354, 17\u201323 (1971).","journal-title":"Virchows Arch. A Pathol. Pathol. Anat."},{"key":"BFsrep04267_CR20","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","volume":"140","author":"P Westermark","year":"1986","unstructured":"Westermark, P., Wernstedt, C., Wilander, E. & Sletten, K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem. Biophys. Res. Commun. 140, 827\u2013831 (1986).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFsrep04267_CR21","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","volume":"84","author":"P Westermark","year":"1987","unstructured":"Westermark, P. et al. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc. Natl. Acad. Sci. U. S. A. 84, 3881\u20133885 (1987).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04267_CR22","first-page":"414","volume":"127","author":"P Westermark","year":"1987","unstructured":"Westermark, P., Wernstedt, C., O'Brien, T. D., Hayden, D. W. & Johnson, K. H. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am. J. Pathol. 127, 414\u2013417 (1987).","journal-title":"Am. J. Pathol."},{"key":"BFsrep04267_CR23","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.1073\/pnas.85.20.7763","volume":"85","author":"GJ Cooper","year":"1988","unstructured":"Cooper, G. J. et al. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 85, 7763\u20137766 (1988).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04267_CR24","first-page":"291","volume":"81","author":"P Westermark","year":"1973","unstructured":"Westermark, P. & Grimelius, L. The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol. Microbiol. Scand. A 81, 291\u2013300 (1973).","journal-title":"Acta Pathol. Microbiol. Scand. A"},{"key":"BFsrep04267_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF01219652","volume":"15","author":"P Westermark","year":"1978","unstructured":"Westermark, P. & Wilander, E. The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia 15, 417\u2013421 (1978).","journal-title":"Diabetologia"},{"key":"BFsrep04267_CR26","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/BF01660981","volume":"421","author":"C R\u00f6cken","year":"1992","unstructured":"R\u00f6cken, C., Linke, R. & Saeger, W. Immunohistology of islet amyloid polypeptide in diabetes mellitus: Semi-qantitative studies in a post-mortem series. Virchows Archiv. A 421, 339\u2013344 (1992).","journal-title":"Virchows Archiv. A"},{"key":"BFsrep04267_CR27","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1016\/S0002-9440(10)64848-1","volume":"157","author":"S Sakagashira","year":"2000","unstructured":"Sakagashira, S. et al. S20G Mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin. Am. J. Pathol. 157, 2101\u20132109 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFsrep04267_CR28","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/368756a0","volume":"368","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A., Razzaboni, B., Weir, G. C. & Yankner, B. A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368, 756\u2013760 (1994).","journal-title":"Nature"},{"key":"BFsrep04267_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/BF00274799","volume":"30","author":"P Westermark","year":"1987","unstructured":"Westermark, P., Wilander, E., Westermark, G. T. & Johnson, K. H. Islet amyloid polypeptide-like immunoreactivity in the islet B cells of Type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia 30, 887\u2013892 (1987).","journal-title":"Diabetologia"},{"key":"BFsrep04267_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00549079","volume":"359","author":"P Westermark","year":"1973","unstructured":"Westermark, P. Fine structure of islets of Langerhans in insular amyloidosis. Virchows Archiv. A 359, 1\u201318 (1973).","journal-title":"Virchows Archiv. A"},{"key":"BFsrep04267_CR31","doi-asserted-by":"publisher","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","volume":"93","author":"J Janson","year":"1996","unstructured":"Janson, J. et al. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc. Natl. Acad. Sci. U. S. A. 93, 7283\u20137288 (1996).","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"BFsrep04267_CR32","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler, A. E., Janson, J., Soeller, W. C. & Butler, P. C. Increased \u03b2-cell apoptosis prevents adaptive increase in \u03b2-cell mass in mouse model of Type 2 diabetes: Evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52, 2304\u20132314 (2003).","journal-title":"Diabetes"},{"key":"BFsrep04267_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","volume":"48","author":"J Janson","year":"1999","unstructured":"Janson, J., Ashley, R. H., Harrison, D., McIntyre, S. & Butler, P. C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 48, 491\u2013498 (1999).","journal-title":"Diabetes"},{"key":"BFsrep04267_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/MED.0b013e32833bf6dc","volume":"17","author":"CA Dinarello","year":"2010","unstructured":"Dinarello, C. A., Donath, M. Y. & Mandrup-Poulsen, T. Role of IL-1\u03b2 in type 2 diabetes. Curr. Opin. Endocrinol. Diabetes. Obes. 17, 314\u2013321 (2010).","journal-title":"Curr. Opin. Endocrinol. Diabetes. Obes."},{"key":"BFsrep04267_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 11, 897\u2013904 (2010).","journal-title":"Nat. Immunol."},{"key":"BFsrep04267_CR36","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1074\/jbc.M809085200","volume":"284","author":"SM Patil","year":"2009","unstructured":"Patil, S. M., Xu, S., Sheftic, S. R. & Alexandrescu, A. T. Dynamic alpha-helix structure of micelle-bound human amylin. J. Biol. Chem. 284, 11982\u201311991 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04267_CR37","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.bbamem.2011.06.012","volume":"1808","author":"RPR Nanga","year":"2011","unstructured":"Nanga, R. P. R., Brender, J. R., Vivekanandan, S. & Ramamoorthy, A. Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim. Biophys. Acta 1808, 2337\u20132342 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFsrep04267_CR38","doi-asserted-by":"publisher","first-page":"17205","DOI":"10.1074\/jbc.M801383200","volume":"283","author":"M Apostolidou","year":"2008","unstructured":"Apostolidou, M., Jayasinghe, S. A. & Langen, R. Structure of alpha-helical membrane-bound human islet amyloid polypeptide and its implications for membrane-mediated misfolding. J. Biol. Chem. 283, 17205\u201317210 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04267_CR39","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1021\/ja710484d","volume":"130","author":"JR Brender","year":"2008","unstructured":"Brender, J. R. et al. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J. Am. Chem. Soc. 130, 6424\u20136429 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"BFsrep04267_CR40","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/pro.145","volume":"18","author":"JJ Wiltzius","year":"2009","unstructured":"Wiltzius, J. J., Sievers, S. A., Sawaya, M. R. & Eisenberg, D. Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process. Protein Sci. 18, 1521\u20131530 (2009).","journal-title":"Protein Sci."},{"key":"BFsrep04267_CR41","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","volume":"87","author":"P Westermark","year":"1990","unstructured":"Westermark, P., Engstrom, U., Johnson, K. H., Westermark, G. T. & Betsholtz, C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. U. S. A. 87, 5036\u20135040 (1990).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04267_CR42","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1021\/bi8014357","volume":"47","author":"RPR Nanga","year":"2008","unstructured":"Nanga, R. P. R., Brender, J. R., Xu, J., Veglia, G. & Ramamoorthy, A. Structures of rat and human islet amyloid polypeptide IAPP1\u221219 in micelles by NMR spectroscopy. Biochemistry 47, 12689\u201312697 (2008).","journal-title":"Biochemistry"},{"key":"BFsrep04267_CR43","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1074\/jbc.271.4.1988","volume":"271","author":"TA Mirzabekov","year":"1996","unstructured":"Mirzabekov, T. A., Lin, M. C. & Kagan, B. L. Pore formation by the cytotoxic islet amyloid peptide amylin. J. Biol. Chem. 271, 1988\u20131992 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04267_CR44","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1073\/pnas.1219059110","volume":"110","author":"NB Last","year":"2013","unstructured":"Last, N. B. & Miranker, A. D. Common mechanism unites membrane poration by amyloid and antimicrobial peptides. Proc. Natl. Acad. Sci. U. S. A. 110, 6382\u20136387 (2013).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04267_CR45","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1021\/bi0121353","volume":"41","author":"MJ Volles","year":"2002","unstructured":"Volles, M. J. & Lansbury, P. T. Vesicle permeabilization by protofibrillar \u03b1-Synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41, 4595\u20134602 (2002).","journal-title":"Biochemistry"},{"key":"BFsrep04267_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1042\/BJ20110749","volume":"441","author":"V Soura","year":"2012","unstructured":"Soura, V. et al. Visualization of co-localization in A\u03b242-administered neuroblastoma cells reveals lysosome damage and autophagosome accumulation related to cell death. Biochem. J. 441, 579\u2013590 (2012).","journal-title":"Biochem. J."},{"key":"BFsrep04267_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4161\/pri.3.2.8859","volume":"3","author":"M Fandrich","year":"2009","unstructured":"Fandrich, M., Meinhardt, J. & Grigorieff, N. Structural polymorphism of Alzheimer Abeta and other amyloid fibrils. Prion 3, 89\u201393 (2009).","journal-title":"Prion"},{"key":"BFsrep04267_CR48","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both \u03b1-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. U. S. A. 97, 571\u2013576 (2000).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep04267_CR49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/418291a","volume":"418","author":"HA Lashuel","year":"2002","unstructured":"Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. & Lansbury, P. T., Jr Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291 (2002).","journal-title":"Nature"},{"key":"BFsrep04267_CR50","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1074\/jbc.M808591200","volume":"284","author":"R Kayed","year":"2009","unstructured":"Kayed, R. et al. Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J. Biol. Chem. 284, 4230\u20134237 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04267_CR51","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1096\/fj.11-194613","volume":"26","author":"M Magzoub","year":"2012","unstructured":"Magzoub, M. & Miranker, A. D. Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J. 26, 1228\u20131238 (2012).","journal-title":"FASEB J."},{"key":"BFsrep04267_CR52","doi-asserted-by":"publisher","first-page":"17294","DOI":"10.1074\/jbc.M500997200","volume":"280","author":"A Demuro","year":"2005","unstructured":"Demuro, A. et al. Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers. J. Biol. Chem. 280, 17294\u201317300 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFsrep04267_CR53","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12017-007-0003-6","volume":"9","author":"Y Yoshiike","year":"2007","unstructured":"Yoshiike, Y., Kayed, R., Milton, S. C., Takashima, A. & Glabe, C. G. Pore-forming proteins share structural and functional homology with amyloid oligomers. Neuromolecular Med. 9, 270\u2013275 (2007).","journal-title":"Neuromolecular Med."},{"key":"BFsrep04267_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ana.21475","volume":"65","author":"A Kellner","year":"2009","unstructured":"Kellner, A. et al. Autoantibodies against beta-amyloid are common in Alzheimer's disease and help control plaque burden. Ann. Neurol. 65, 24\u201331 (2009).","journal-title":"Ann. Neurol."},{"key":"BFsrep04267_CR55","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1471-4159.2006.04365.x","volume":"101","author":"KK Papachroni","year":"2007","unstructured":"Papachroni, K. K. et al. Autoantibodies to alpha-synuclein in inherited Parkinson's disease. J. Neurochem. 101, 749\u2013756 (2007).","journal-title":"J. Neurochem."},{"key":"BFsrep04267_CR56","doi-asserted-by":"publisher","first-page":"e18513","DOI":"10.1371\/journal.pone.0018513","volume":"6","author":"K Yanamandra","year":"2011","unstructured":"Yanamandra, K. et al. Alpha-synuclein Reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients. PLoS ONE. 6, e18513 (2011).","journal-title":"PLoS ONE."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep04267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04267","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep04267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T08:39:30Z","timestamp":1672994370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep04267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,4]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep04267"],"URL":"https:\/\/doi.org\/10.1038\/srep04267","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,4]]},"assertion":[{"value":"22 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4267"}}